Our Featured Experts

Sara Hurvitz, MD
Dr. Hurvitz on the Potential Global Impact of Biosimilars in Breast Cancer
Sara Hurvitz, MD, associate professor, David Geffen School of Medicine, UCLA; medical director, Jonsson Comprehensive Cancer Center Clinical Research Unit; co-director, Santa Monica-UCLA Outpatient Oncology Practices; and director, Breast Cancer Clinical Trials Program, UCLA, discusses the potential global impact of biosimilars in breast cancer.
Ken Y. Yoneda, MD
Oncology Specialists
Publication Bottom Border
Border Publication
x